Inhibition of T cell responses by transferrin-coupled competitor peptides

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 77-85

  Zaliauskiene, L ^a   Fazio, R L ^a   Kang, S ^a   Sparks, K ^a   Weaver, C T ^b   Zinn, K R ^c   Collawn, J F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Autoreactive T cells; Competitor peptides; Immunosuppression; Major histocompatibility complex class II; Transferrin

Indexed keywords

AUTOANTIGEN; CELL SURFACE RECEPTOR; COMPETITOR PEPTIDE; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; LIGAND; PEPTIDE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; LIGAND BINDING; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; BINDING, COMPETITIVE; CROSS-LINKING REAGENTS; ENDOCYTOSIS; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES; TRANSFERRIN;

EID: 0036394261     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:26:1-3:077     Document Type: Article

References (22)

1. Svejgaard A, Platz P, Ryder LP: HLA and disease 1982 - a survey. Immunol Rev 1983;70:193-218.
2. Werdelin O: Chemically related antigens compete for presentation by accessory cells to T cells. J Immunol 1982;129:1883-1891.
3. Babbitt BP, Matsueda G, Haber E, Unanue ER, Allen PM: Antigenic competition at the level of peptideIa binding. Proc Natl Acad Sci USA 1986;83:4509-4513.
4. Adorini L, Muller S, Cardinaux F, Lehmann PV, Falcioni F, Nagy ZA: In vivo competition between self peptides and foreign antigens in T-cell activation. Nature 1988;334:623-625.
5. Lorenz RG, Blum JS, Allen PM: Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. J Immunol 1990;144:1600-1606.
6. Lanzavecchia A: Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990;8:773-793.
7. Legge KL, Min B, Potter NT, Zaghouani H: Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J Exp Med 1997;185:1043-1053.
8. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769-779.
9. Lock C, Smilek D, Gautam A, Vaysburd M, Dwivedy S, McDevitt H: Competitive inhibition of antigen presentation in animal models of autoimmune disease. Semin Immunol 1991;3:247-255.
10. Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001;19:275-290.
11. Tschoetschel U, McCoy KL, Reske-Kunz AB: Augmented antigen presentation by mouse Ia + T clone cells BK-BI-2.6.O4.1 mediated by transferrin receptors. Scand J Immunol 1996;43:500-506.
12. + T cells. J Immunol 1993;150:1691-1704.
13. Niebling WL, Pierce SK: Antigen entry into early endosomes is insufficient for mhc class II processing. J Immunol 1993;150:2687-2697.
14. Mauri D, Wyss-Coray T, Brander C, Pichler WJ: Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentation. Cell Immunol 1994;158:59-70.
15. Mellman I, Turley SJ, Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 1998;8:231-237.
16. Zaliauskiene L, Kang S, Brouillette C, Lebowitz J, Arani RB, Collawn JF: Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain. Mol Biol Cell 2000;11(8):2643-2655.
17. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
18. Ceppellini R, Frumento G, Ferrara GB, Rosi R, Chersi A, Pernis B: Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature 1989;339:392-394.
19. Zinn KR, Douglas JT, Smyth CA, Liu H-G, Wu Q, Krasnykh VN, Mountz JD, Curiel DT, Mountz JM: Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5). Gene Ther 1998;5:798-808.
20. Kearney ER, Pape KA, Loh DY, Jenkins MK: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
21. Liu H, Rhodes M, Wiest DL, Vignali DA: On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 2000;13:665-675.
22. Fulcher DA, Lyons AB, Korn SL, Cook MC, Koleda C, Parish C, Fazekas de St Groth B, Basten A: The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996;183:2313-2328